Document is current
Any future updates will be listed below
-
Authors
Chongsaritsinsuk, Joann
Steigmeyer, Alexandra D. https://orcid.org/0000-0001-9805-4012
Mahoney, Keira E. https://orcid.org/0000-0003-4561-9838
Rosenfeld, Mia A. https://orcid.org/0000-0002-8961-8231
Lucas, Taryn M. https://orcid.org/0000-0002-1697-0939
Smith, Courtney M.
Li, Alice
Ince, Deniz
Kearns, Fiona L.
Battison, Alexandria S. https://orcid.org/0000-0002-4381-873X
Hollenhorst, Marie A.
Judy Shon, D. https://orcid.org/0000-0001-8379-6195
Tiemeyer, Katherine H. https://orcid.org/0000-0001-5691-8281
Attah, Victor
Kwon, Catherine
Bertozzi, Carolyn R. https://orcid.org/0000-0003-4482-2754
Ferracane, Michael J. https://orcid.org/0000-0002-3007-3126
Lemmon, Mark A. https://orcid.org/0000-0002-3379-5319
Amaro, Rommie E. https://orcid.org/0000-0002-9275-9553
Malaker, Stacy A. https://orcid.org/0000-0003-2382-5067
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35-GM147039)
- License Information
-
More Information
Article History
Received: 5 February 2023
Accepted: 11 September 2023
First Online: 4 October 2023
Competing interests
: F.L.K. is a consultant for Protein Evolution, Inc. M.A.H. received consulting fees from Dova Pharmaceuticals, Janssen Pharmaceuticals, and Sonder Capital. C.R.B. is a co-founder and scientific advisory board member of Lycia Therapeutics, Palleon Pharmaceuticals, Enable Bioscience, Redwood Biosciences (a subsidiary of Catalent) OliLux Bio, Grace Science LLC, and InterVenn Biosciences. S.A.M. is a consultant for InterVenn Biosciences and Arkuda Therapeutics. S.A.M., D.J.S., and C.R.B. are coinventors on a Stanford nonprovisional utility patent application that has been filed and is pending in the US (number US20220003777) related to the use of mucinases for mass spectrometry analysis of mucin-domain glycoproteins. The remaining co-authors have no conflicts of interest to disclose.
